Zomedica Corp. (ZOMDF)
OTCMKTS
· Delayed Price · Currency is USD
0.0500
+0.0140 (38.89%)
Mar 14, 2025, 4:00 PM EST
Zomedica Employees
Zomedica had 144 employees as of December 31, 2023. The number of employees increased by 59 or 69.41% compared to the previous year.
Employees
144
Change (1Y)
59
Growth (1Y)
69.41%
Revenue / Employee
$189,479
Profits / Employee
-$326,264
Market Cap
49.05M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
Zomedica News
- 3 days ago - Zomedica Corp. (ZOMDF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth - Accesswire
- 12 days ago - Zomedica Corp. Announces Transition to OTCQB Venture Market - Accesswire
- 12 days ago - NYSE American to Commence Delisting Proceedings Against Zomedica Corp. (ZOM) - Business Wire
- 18 days ago - Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET - Accesswire
- 4 weeks ago - Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters - Accesswire
- 5 weeks ago - Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis - Accesswire
- 2 months ago - Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market - Accesswire